Skip to Content
MarketWatch

Alarm raised about India's COVID-19 variant, as pandemic keeps spreading in country

By Pierre Briançon

Cases of mucormycosis, a rare black fungus that invades the brain, with a high mortality rate, have appeared among vulnerable COVID-19 patients in India

The World Health Organization has classified (link) a variant of the coronavirus that causes COVID-19 detected in India as one of "concern at a global level," based on studies showing increased risks of transmissibility. Infections and deaths remained near their record highs in India on Monday.

Read: India's COVID crisis deepens, as BioNTech says there's no evidence its vaccine needs adapting to cope with new variants (link)

The outlook: More information about the Indian variant is due to be released this week, the WHO said. But many countries (link), such as Canada, Australia, the U.K. and Italy, have already banned entry to visitors from India.

Read:Different strokes for different folks as Europe eases out of lockdowns (link)

-; 415-439-6400; AskNewswires@dowjones.com

 

(END) Dow Jones Newswires

05-12-21 0429ET

Copyright (c) 2021 Dow Jones & Company, Inc.

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

  • Verify your identity, personalize the content you receive, or create and administer your account.
  • Provide specific products and services to you, such as portfolio management or data aggregation.
  • Develop and improve features of our offerings.
  • Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.